REPLICEL LIFE SCIENCES INC. (REPCF) Financial Statements
REPLICEL LIFE SCIENCES INC. (REPCF) files with the U.S. Securities and Exchange Commission under CIK 0001205059. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2022
- Net Income
- -743.23 thousand CAD
- Total Assets
- 798.22 thousand CAD
- Net Cash from Operations
- -1.41 million CAD
Fiscal year ended Dec 31, 2022. Latest periodic SEC filing: May 2, 2023. Source: SEC filings (EDGAR XBRL). Amounts in CAD.
Open the full financial statements for REPCF in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History